Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
RFK removes all ACIP members, names new ones; National Resilience to close six sites; Deals and financing recap of ...
Yesterday
Weekly
Former CEO Anne Wojcicki wins bid for 23andMe
Yesterday
Deals
Health Tech
KalVista says FDA delayed decision on HAE drug, citing ‘heavy workload’
Yesterday
Pharma
FDA+
FDA's oncology adcomm to review GSK's Blenrep relaunch plans
Yesterday
Pharma
FDA+
Another round of consolidation is coming, FDA commissioner tells staff
Yesterday
People
FDA+
With HIV prevention under attack, how might Gilead’s new PrEP injection fare?
2 days ago
Pharma
In Focus
Rein Therapeutics study on clinical hold; Beam updates sickle cell therapy data
2 days ago
News Briefing
Bristol Myers gets a key strategist with 'Team Shibs'; Idorsia to change CEOs after it 'hit a reset button'
2 days ago
Peer Review
AstraZeneca inks AI drug R&D deal with Chinese pharma for $110M upfront
2 days ago
R&D
China
Moderna wins expanded label for RSV shot, allowing use in at-risk, younger adults
2 days ago
Pharma
FDA+
Minnesota generic drug pricing law is likely unconstitutional, appeals court rules
2 days ago
Pharma
Law
Novo Nordisk plans Phase 3 trials of oral, injectable amycretin for early 2026
2 days ago
R&D
Pharma
Kennedy's vaccine doubts hinge on 'inert' placebos, but experts say he misunderstands the science
2 days ago
Pharma
FDA+
CureVac CEO on BioNTech deal: Come together 'rather than fighting each other in court'
2 days ago
Deals
Another care navigation deal
2 days ago
Health Tech
In surprise, FDA approves UroGen's chemo-turned-gel drug after negative adcomm vote
2 days ago
Pharma
FDA+
Exclusive: Kennedy picks for vaccine advisory board were paid experts against Merck in civil cases
2 days ago
R&D
Pharma
Insmed aims to raise $750M in one of the largest stock offerings this year
2 days ago
Financing
R&D
Kura, Kyowa say Phase 1 update supports menin inhibitor combos
2 days ago
R&D
ADC Therapeutics reveals layoffs, $100M PIPE; Third Harmonic seeks buyer for asset
3 days ago
News Briefing
Capricor gets Form 483 from FDA; WuXi Biologics' new China factory
3 days ago
Manufacturing
Exclusive: Commons Clinic raises $26M Series B to offer preventive testing
3 days ago
Financing
Startups
BioNTech to acquire CureVac in all-stock deal valued at $1.25B
3 days ago
Deals
Schrödinger says early MALT1 data could lay 'great foundation' for combos
3 days ago
R&D
1
2
3
4
Next page
Last page